Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
Pneumococcal disease
Type of publications
NITAG documentation (88)
Reports (1)
SAGE documentation (8)
Scientific publications (1)
Systematic reviews (SYSVAC) (168)
Regions
Africa (11)
Americas (52)
Eastern Mediterranean (1)
Europe (39)
South-East Asia (4)
Western Pacific (15)
Diseases
Pneumococcal disease (266)
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (9)
Moderate (2)
Low (13)
Critically low (80)
Not applicable (64)
266 results found
2023
∙
Buja, A. Grotto, G. Taha, M. Cocchio, S. Baldo, V.
Use of Information and Communication Technology Strategies to Increase Vaccination Coverage in Older Adults: A Systematic Review
2023
∙
Sikjær, M. G. Pedersen, A. A. Wik, M. S. Stensholt, S. S. Hilberg, O. Løkke, A.
Vaccine effectiveness of the pneumococcal polysaccharide and conjugated vaccines in elderly and high-risk populations in preventing invasive pneumococcal disease: a systematic search and meta-analysis
2023
∙
ACIP
Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
2023
∙
Haute Autorité de Santé
Vaccination strategy against pneumococcal infections - Place of pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed) in adults
2023
Pneumococcal vaccination of children in the netherlands
2023
Pneumococcal vaccination of the elderly in the netherlands
2023
∙
NACI
Recommendations on the use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: Economic evidence supplementary appendix
2023
∙
NACI
Public health level recommendations on the use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines
2023
∙
NACI
Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations
2023
∙
Conseil Supérieur de la Santé (CSS)
Pneumococcal vaccination in children and adolescents in Belgium
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register